Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction

Proliferation of T cells is important for the expansion of specific T cell clones during immune responses. In addition, for the establishment of protective immunity against viruses, bacteria, and tumors, the expanded T cells must differentiate into effector T cells. Here we show that effector T cell generation is driven by activation of APCs and duration of antigenic stimulation. Adoptively transferred TCR-transgenic T cells extensively proliferated upon immunization. However, these T cells failed to differentiate into effector cells and died within 1 wk after immunization unless antigenic peptides persisted for >1 day or were presented by activated APCs. The induction of protective immunity in a nontransgenic system was more stringent, since activation of APCs or prolonged Ag persistence alone was not sufficient to drive immunity. In contrast, Ag had to be presented for several days by activated APCs to trigger protective T cell responses. Thus, activation of APCs and duration of Ag presentation together regulate the induction of protective T cell responses.

[1]  Javier Hernández,et al.  Uncoupling of Proliferative Potential and Gain of Effector Function by CD8+ T Cells Responding to Self-Antigens , 2002, The Journal of experimental medicine.

[2]  Pamela S. Ohashi,et al.  T-cell signalling and autoimmunity: molecular mechanisms of disease , 2002, Nature Reviews Immunology.

[3]  A. Jegerlehner,et al.  Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1 , 2002, The Journal of Immunology.

[4]  F. Lechner,et al.  Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.

[5]  G. Belz,et al.  Cutting Edge: Precursor Frequency Affects the Helper Dependence of Cytotoxic T Cells1 , 2002, The Journal of Immunology.

[6]  B. Beutler Toll-like receptors: how they work and what they do , 2002, Current opinion in hematology.

[7]  E. Pamer,et al.  Priming of Memory But Not Effector CD8 T Cells by a Killed Bacterial Vaccine , 2001, Science.

[8]  Javier Hernández,et al.  Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-Antigen , 2001, The Journal of experimental medicine.

[9]  R. Zinkernagel,et al.  Regulation of the Immune Response by Antigen , 2001, Science.

[10]  F. Sallusto,et al.  Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.

[11]  Susan M. Kaech,et al.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.

[12]  Stephen P. Schoenberger,et al.  Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.

[13]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[14]  I. N. Crispe,et al.  Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo. , 2000, Immunity.

[15]  L. Nguyen,et al.  Role of Antigen-Presenting Cells in Mediating Tolerance and Autoimmunity , 2000, The Journal of experimental medicine.

[16]  D. Pardoll,et al.  Cd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T Lymphocytes , 2000, The Journal of experimental medicine.

[17]  M. Bachmann,et al.  The role of T-cell receptor dimerization in T-cell activation. , 1999, Immunology today.

[18]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[19]  H. Bien,et al.  Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40 , 1999, Nature Medicine.

[20]  T. Schumacher,et al.  CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy , 1999, Nature Medicine.

[21]  M. Bachmann,et al.  CD8+ T Cells Mediate CD40-independent Maturation of Dendritic Cells In Vivo , 1999, The Journal of experimental medicine.

[22]  J. Opferman,et al.  Linear differentiation of cytotoxic effectors into memory T lymphocytes. , 1999, Science.

[23]  Christine Zimmermann,et al.  Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences , 1999, European journal of immunology.

[24]  M. Bachmann,et al.  Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection , 1999, European journal of immunology.

[25]  J. Altman,et al.  Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.

[26]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[27]  S Oehen,et al.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.

[28]  Chyung-Ru Wang,et al.  Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.

[29]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[30]  R. Zinkernagel,et al.  Peptide‐induced T cell receptor down‐regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation , 1997, European journal of immunology.

[31]  D. Hanahan,et al.  Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy , 1997, The Journal of experimental medicine.

[32]  C. Kurts,et al.  Class I–restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells , 1997, The Journal of experimental medicine.

[33]  R. Zinkernagel,et al.  Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Pircher,et al.  On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Schuler,et al.  High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] , 1996, The Journal of experimental medicine.

[36]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[37]  R. Germain,et al.  Partial signaling by CD8+ T cells in response to antagonist ligands , 1996, The Journal of experimental medicine.

[38]  R. Offringa,et al.  Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. , 1996, Journal of immunology.

[39]  H. Pircher,et al.  T cell priming versus T cell tolerance induced by synthetic peptides , 1995, The Journal of experimental medicine.

[40]  R. Zinkernagel,et al.  Induction of protective cytotoxic T cells with viral proteins , 1994, European journal of immunology.

[41]  Hans Hengartner,et al.  T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides , 1993, European journal of immunology.

[42]  R. Zinkernagel,et al.  Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus , 1993, Journal of virology.

[43]  P. Allen,et al.  Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. , 1993, Journal of immunology.

[44]  R M Zinkernagel,et al.  Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.

[45]  P. Allen,et al.  Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.

[46]  H. Pircher,et al.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.

[47]  M. Merkenschlager,et al.  Memory T cells , 1989, Nature.

[48]  R. Germain,et al.  The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. , 1999, Annual review of immunology.

[49]  J. Altman,et al.  In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. , 1998, Advances in experimental medicine and biology.

[50]  P. Allen,et al.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.

[51]  M. Bevan,et al.  T cell receptor antagonists and partial agonists. , 1995, Immunity.

[52]  M. Battegay [Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates] , 1993, ALTEX.

[53]  M. Buchmeier,et al.  Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. , 1985, British medical bulletin.

[54]  F. Lehmann-Grube Portraits of viruses: arenaviruses. , 1984, Intervirology.